Clinical trial
The ASCEND Study: A Clinical Evaluation of the UP Drug-Coated Device in Patients With Chronic Rhinosinusitis
NCT03599271 is registered in ClinicalTrials.gov with Intersect ENT as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The ASCEND Study: A Clinical Evaluation of the UP Drug-Coated Device in Patients With Chronic Rhinosinusitis
- Lead sponsor
- Intersect ENT
- Phase
- Not reported
- Overall status
- Completed
- Start date
- June 12, 2018
- Completion date
- December 9, 2020
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic rhinosinusitis (diagnosis)